3rd Annual Research Round-Up with Laura Amendola, MS, CGC, Carrie Horton, MS, CGC, and Holly LaDuca, MS, CGC

Join us!

Let’s look back at 2025 research with a fast, focused review of the most impactful genetics papers of the year and what they mean for real world clinical decision making. In this live, 60minute webinar, Ambry’s experts will break down key findings, highlight clinical implications across oncology and rare disease, and share practical guidance you can apply immediately.

During this engaging session, Ambry experts will present 10 of the most significant publications from 2025 in a fast-paced, journal club-style format.

You’ll learn:
- Which 2025 publications matter most, from newly released guidelines to the implementation of genetics into primary care —and why they rise above the noise
- How new evidence should influence testing strategies, reporting, and followup care
- Emerging research topics to watch in 2026

Laura Amendola, MS, CGC | Presenter

Clinical Strategy Manager at Ambry Genetics

Laura Amendola works in clinical strategy at Ambry with a focus on rare disease and is passionate about integrating scalable genomic testing into clinical practice. She started her career as a clinical genetic counselor and then spent almost a decade in academia as part of NIH-funded research consortia evaluating the clinical integration of genomic sequencing. Prior to joining Ambry, Laura led genome screening initiatives in the Medical Genomics Research group at Illumina, Inc. and worked with the Clinical Sequencing Program at the National Institute of Allergy and Infectious Disease. Laura has published extensively on a range of topics in genomic medicine and contributed to the genetics community through her volunteer work with NSGC and ACMG.

Carrie Horton, MS, CGC | Presenter

Clinical Strategy Manager - Clinical Research & Collaborations at Ambry Genetics

Ms. Horton received her M.S. in Genetic Counseling from Arcadia University and practiced clinically as a cancer genetic counselor in Memphis, TN prior to joining Ambry Genetics 9 years ago. During her time at Ambry, she first took on the role of reporting genetic counselor, performing variant assessment and generating test reports. She has also acted as a Senior Clinical Research Specialist, conducting studies that focus on the translational application of Ambry's research to solve clinical dilemmas in the oncology setting. In her current role as Medical Science Liaison for Clinical Research, she coordinates multi-disciplinary and multi-institutional initiatives to improve engagement, promotion, and dissemination of key research findings. Ms. Horton's research interests include improving the clinical utility of and increasing access to genetic testing.

Holly LaDuca, MS, CGC | Presenter

Clinical Strategy Manager at Ambry Genetics

Holly LaDuca is a Clinical Strategy Manager at Ambry Genetics, focusing on hereditary cancer. After beginning her career as a community-based cancer genetic counselor, she has spent over 10 years applying her genetic counseling skillset in laboratory and digital health settings. During this time, she has collaborated on 60+ publications. Ms. LaDuca is concurrently pursuing a PhD in Translational Health Science to help bridge gaps between research and practice and to integrate implementation science principles into clinical genetics and precision public health. She also enjoys engaging with genetic counseling students, especially to support thesis projects.